Resistance to TB drugs
Primary MDR-TB occurs in patients who have not previously been infected with TB but who become infected with a strain that is resistant to treatment. Acquired MDR-TB occurs in patients during treatment with a drug regimen that is not effective at killing the particular strain of TB with which they have been infected Treatment of MDR-TB requires treatment with second-line drugs, usually four or more anti-TB drugs for a minimum of 6 months, and possibly extending for 18–24 months if rifampin resistance has been identified in the specific strain of TB with which the patient has been infected.In general, second-line drugs are less effective, more toxic and much more expensive than first-line drugs. Under ideal program conditions, MDR-TB cure rates can approach 70%.
- Intrinsic drug resistance
- Acquired drug resistance
- Resistance and biological fitness
- New drugs and new targets
- new resistance mechanisms
Related Conference of Resistance to TB drugs
March 24-25, 2025
8th International Conference on Clinical Microbiology, Virology and Infectious Diseases
Paris, France
May 20-21, 2025
6th International Conference on Applied Microbiology and Infectious Diseases
Vancouver, Canada
August 07-08, 2025
11th International Congress on Trauma, Critical Care and Emergency Medicine
Paris, France
August 25-26, 2025
20th International Conference on Microbial Interactions & Microbial Ecology
London, UK
October 06-07, 2025
20th International Conference on Virology, Emerging Diseases & vaccines
Vancouver, Canada
November 17-18, 2025
10th International Conference on Molecular Medicine and Diagnostics
Paris, France
November 17-18, 2025
9th International Conference on Microbiome, Probiotics & Gut Nutrition
Vancouver, Canada
December 11-12, 2025
8th International Conference on Antimicrobial and Antibacterial Agents
Prague, Czech Republic
Resistance to TB drugs Conference Speakers
Recommended Sessions
- : Causes of Tuberculosis
- Challenges in TB diagnostics
- Diagnosis
- Epidemiology of the disease
- Genome
- Intoduction to Tuberculosis
- Mycobacterium tuberculosis infection
- New research and development
- Pathogenesis
- Prevention
- Pulmonary disorders
- Resistance to TB drugs
- Surveillance and Tracking of Drug-Resistant TB
- Symptoms
- TB and HIV co-infection
- TB clinical trials
- Treatment (Vaccines & Immunization)
Related Journals
Are you interested in
- Environmental Biology - Applied Microbiology 2025 (Canada)
- Acute Care Surgery - TRAUMA 2025 (France)
- Advanced Research In Microbiology - Applied Microbiology 2025 (UK)
- Advances in Applied Microbiology - Applied Microbiology 2025 (UK)
- Agriculture & Forest Microbiology - Microbiology 2025 (Germany)
- Agriculture & Forest Microbiology - Microbial Interactions 2025 (UK)
- Animal Virology - Euro Virology 2025 (France)
- Anti-Retroviral Therapy - Euro Virology 2025 (France)
- Antimicrobial Agents & Resistance - Microbiology 2025 (Germany)
- Antimicrobial Agents & Resistance - Microbial Interactions 2025 (UK)
- Antiviral Drug Discovery and Development - Euro Virology 2025 (France)
- Applied and Environmental Science - Microbiology 2025 (Germany)
- Applied and Environmental Science - Microbial Interactions 2025 (UK)
- Applied Microbiology - Applied Microbiology 2025 (Canada)
- Applied Microbiology in Animals - Applied Microbiology 2025 (Canada)
- Aquatic & Marine Microbiology - Microbiology 2025 (Germany)
- Aquatic & Marine Microbiology - Microbial Interactions 2025 (UK)
- Bacterial and Fungal Virology - Euro Virology 2025 (France)
- Bacteriology - Applied Microbiology 2025 (Canada)
- Bacteriology, Bacterial Pathogens & Associated diseases - Microbiology 2025 (Germany)
- Biotechnology - Applied Microbiology 2025 (UK)
- Burns and Thermal Injuries - TRAUMA 2025 (France)
- Cardiac and Vascular Emergencies - TRAUMA 2025 (France)
- Cellular Microbiology & Systems Microbiology - Microbiology 2025 (Germany)
- Cellular Microbiology & Systems Microbiology - Microbial Interactions 2025 (UK)
- Clinical and Diagnostic Virology - Euro Virology 2025 (France)
- Clinical and Neuro Virology - Virology-2025 (Canada)
- Clinical and Public Health Microbiology - Microbiology 2025 (Germany)
- Clinical and Public Health Microbiology - Microbial Interactions 2025 (UK)
- Clinical Infections and Vaccines - Microbiology 2025 (Germany)
- Clinical microbiology - Applied Microbiology 2025 (UK)
- Coronavirus (COVID-19) - Euro Virology 2025 (France)
- Critical Care Medicine - TRAUMA 2025 (France)
- Current Focus in Virology Research - Euro Virology 2025 (France)
- Emergency Nursing and Trauma Care - TRAUMA 2025 (France)
- Emerging infectious diseases and the - Virology-2025 (Canada)
- Emerging Infectious Diseases in Critical Care - TRAUMA 2025 (France)
- Environmental Microbiology - Applied Microbiology 2025 (UK)
- Environmental Microbiology (Soil Microbiology & Water Microbiology) - Microbiology 2025 (Germany)
- Epidemiology of Re-Emerging Infectious Diseases - Virology-2025 (Canada)
- Ethics, Legal, and Policy Issues in Critical Care - TRAUMA 2025 (France)
- Food & Marine Microbiology - Microbial Interactions 2025 (UK)
- Food Borne Diseases and Prevention - Food Microbiology-2025 (UK)
- Food Microbiology - Microbiology 2025 (Germany)
- Food Microbiology - Applied Microbiology 2025 (UK)
- Food Microbiology - Food Microbiology-2025 (UK)
- Food Microbiology and Food Market - Microbiology 2025 (Germany)
- Food Mycology - Food Microbiology-2025 (UK)
- Food Safety and Quality - Food Microbiology-2025 (UK)
- Gastrointestinal viral diseases - Euro Virology 2025 (France)
- General Virology - Virology-2025 (Canada)
- General Virology - Euro Virology 2025 (France)
- Geomicrobiology - Applied Microbiology 2025 (Canada)
- Geriatric Trauma and Emergency Care - TRAUMA 2025 (France)
- Global Health and Trauma Care - TRAUMA 2025 (France)
- Hepatic viral diseases - Euro Virology 2025 (France)
- Host-Pathogen Interaction - Microbial Interactions 2025 (UK)
- Host-Pathogen Interactions - Applied Microbiology 2025 (Canada)
- Human Micro Biota - Applied Microbiology 2025 (Canada)
- Immunization and Immunotherapeutics - Virology-2025 (Canada)
- Industrial Microbiology - Applied Microbiology 2025 (UK)
- Industrial Microbiology, Microbial Biotechnology and Future Bioindustries - Microbiology 2025 (Germany)
- Industrial Microbiology, Microbial Biotechnology and Future Bioindustries - Microbial Interactions 2025 (UK)
- Influenza and other Respiratory Diseases - Virology-2025 (Canada)
- Innovations and Technology in Trauma and Critical Care - TRAUMA 2025 (France)
- Insect vector and virus epidemiology - Euro Virology 2025 (France)
- Measles as re-emerging infectious disease - Virology-2025 (Canada)
- Medical Microbiology - Applied Microbiology 2025 (UK)
- Medical Parasitology - Microbiology 2025 (Germany)
- Microbial Biodegradation - Microbial Interactions 2025 (UK)
- Microbial Biotechnology - Applied Microbiology 2025 (UK)
- Microbial Community - Microbial Interactions 2025 (UK)
- Microbial Cytology, Microbial Physiology & Recombination DNA - Microbiology 2025 (Germany)
- Microbial Diseases - Microbial Interactions 2025 (UK)
- Microbial Ecology and Evolution - Microbiology 2025 (Germany)
- Microbial Ecology and Evolution - Microbial Interactions 2025 (UK)
- Microbial Ecology of Food - Food Microbiology-2025 (UK)
- Microbial Interactions - Microbial Interactions 2025 (UK)
- Microbial Pathogenesis - Microbial Interactions 2025 (UK)
- Microbiology - Euro Virology 2025 (France)
- Microbiology & Infectious Diseases - Microbial Interactions 2025 (UK)
- Microbiology & Microbes World - Applied Microbiology 2025 (Canada)
- Microbiology & Molecular Biology: - Applied Microbiology 2025 (UK)
- Microbiology of Fermented Foods and Beverages - Food Microbiology-2025 (UK)
- Microorganisms in Pharmaceutical Industry - Applied Microbiology 2025 (Canada)
- Military and Combat Trauma - TRAUMA 2025 (France)
- Molecular and Cellular Virology - Euro Virology 2025 (France)
- Molecular Microbiology - Microbiology 2025 (Germany)
- Molecular Microbiology - Microbial Interactions 2025 (UK)
- Mycology, Fungal Pathogens and Associated Diseases - Microbiology 2025 (Germany)
- Mycology, Fungal Pathogens and Associated Diseases - Microbial Interactions 2025 (UK)
- Neurologic viral diseases - Euro Virology 2025 (France)
- Neurological Emergencies and Trauma - TRAUMA 2025 (France)
- New and Endogenous Retroviruses - Virology-2025 (Canada)
- Novel Antiviral Therapies - Virology-2025 (Canada)
- Novel Vaccine Delivery Methods - Virology-2025 (Canada)
- Oral Microbiology - Applied Microbiology 2025 (Canada)
- Pediatric and Neonatal Emergency Care - TRAUMA 2025 (France)
- Pediatric Viral Infectious Diseases - Euro Virology 2025 (France)
- Pharmaceutical microbiology - Applied Microbiology 2025 (UK)
- Phycology, Nematology & Protozoology - Microbiology 2025 (Germany)
- Plant and Agricultural Virology - Euro Virology 2025 (France)
- Plant Pathology & Microbiology - Microbiology 2025 (Germany)
- Plant Pathology & Microbiology - Microbial Interactions 2025 (UK)
- Plant-Soil Microbe Interactions - Microbial Interactions 2025 (UK)
- Probiotics & Prebiotics - Applied Microbiology 2025 (Canada)
- Profession of Microbiology - Microbiology 2025 (Germany)
- Psychosocial Aspects of Trauma and Critical Care - TRAUMA 2025 (France)
- Public health & Epidemiology - Applied Microbiology 2025 (Canada)
- Respiratory viral diseases - Euro Virology 2025 (France)
- Resuscitation and Emergency Response - TRAUMA 2025 (France)
- Risk Assessment and Risk Management - Food Microbiology-2025 (UK)
- Soil microbiology & Water Microbiology - Microbial Interactions 2025 (UK)
- STD & HIV/ AIDS and Emerging Viral Diseases - Euro Virology 2025 (France)
- STD's and Non-Viral STIs - Virology-2025 (Canada)
- Structural and Molecular virology - Virology-2025 (Canada)
- Transmission of Viruses - Virology-2025 (Canada)
- Transplant-Associated Viral Infections - Virology-2025 (Canada)
- Trauma and Emergency Care Research - TRAUMA 2025 (France)
- Trauma and Emergency Medicine - TRAUMA 2025 (France)
- Trauma and Emergency Medicine Education - TRAUMA 2025 (France)
- Trauma Imaging and Diagnostics - TRAUMA 2025 (France)
- Trauma Rehabilitation and Recovery - TRAUMA 2025 (France)
- Uses of Microorganisms in Food - Food Microbiology-2025 (UK)
- Vaccines against Emerging Diseases (Ebola/Zika/Dengue/Chik) - Virology-2025 (Canada)
- Vaccines against tropical and neglected diseases - Virology-2025 (Canada)
- Vaccines and the Microbiome - Virology-2025 (Canada)
- Veterinary Microbiology - Microbiology 2025 (Germany)
- Veterinary virology - Virology-2025 (Canada)
- Viral Genetics, Evolution and Dynamics - Virology-2025 (Canada)
- Viral Immunology - Euro Virology 2025 (France)
- Viral Immunology and Immunopathology - Virology-2025 (Canada)
- Viral Oncology - Virology-2025 (Canada)
- Viral Oncology - Euro Virology 2025 (France)
- Viral Pathogenesis - Virology-2025 (Canada)
- Viral Vaccines - Euro Virology 2025 (France)
- Virology, Viral Pathogens and Associated Diseases - Microbiology 2025 (Germany)